Gavin David Clark

Gavin David Clark founded Procela Partners and MGB Biopharma Ltd., where he worked as Director & Chief Business Officer.
Dr. Clark also currently works at Lamellar Biomedical Ltd., as Non-Executive Director.
Dr. Clark also formerly worked at Angel Biotechnology Holdings Plc, as Non-Executive Director from 2008 to 2012, Johnson & Johnson, as Principal, Bayer AG, as Product Manager, Acumen Pharmaceuticals, Inc., as Vice President-Corporate Development, Pintex Pharmaceuticals, Inc., as Principal, Janssen-Cilag Ltd., as Product Manager, RioTech Pharmaceuticals Ltd., as Executive Vice President-Corporate Development, PLIVA dd, as Principal, GlaxoWellcome, as Principal, Physiomics Plc, as Principal, PowderMed Ltd., as Principal, GlycoForm Ltd., as Head-Business Development from 2008 to 2011, Novartis Pharmaceuticals Corp., as Principal, Affimed NV Niederlassung Deutschland, as Vice President-Business Development, NeuroCure Ltd., as Principal, Tibotec Pharmaceuticals, as Vice President-Business Development, Immunovo BV, as Vice President-Business Development, and Netherlands Translational Research Center BV, as Vice President-Business Development.
Dr. Clark received his undergraduate degree from the University of Strathclyde.